The global Anticoagulant Reversal Drugs Market, valued at US$ 829.5 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2031, reaching more than US$ 2.3 billion by 2031. Anticoagulant reversal drugs, such as idarucizumab and andexanet alfa, are used to reverse the effects of anticoagulants in cases of life-threatening bleeding or emergency...

Anticoagulant Reversal Drugs Market, By Drugs (Phytonadione, Coagulation Factor Xa, Idarucizumab, and Others), Indication (Heparin Overdose, Reversal of Anticoagulation, and Others), Route of Administration (Oral and Injectable), End-Users (Hospitals, Homecare, Speciality Centres, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Industry Trends...